Cooper Companies (COO) Competitors $81.50 -0.41 (-0.50%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock COO vs. WST, ALGN, MMSI, ICUI, HAE, XRAY, QDEL, NEOG, STAA, and CERSShould you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry. Cooper Companies vs. West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA QuidelOrtho Neogen STAAR Surgical Cerus West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, dividends, profitability, earnings, media sentiment, valuation and risk. Do institutionals and insiders hold more shares of WST or COO? 93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 2.0% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, WST or COO? West Pharmaceutical Services has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Does the media refer more to WST or COO? In the previous week, West Pharmaceutical Services had 18 more articles in the media than Cooper Companies. MarketBeat recorded 57 mentions for West Pharmaceutical Services and 39 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 1.01 beat West Pharmaceutical Services' score of 0.39 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 15 Very Positive mention(s) 6 Positive mention(s) 28 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Cooper Companies 22 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor WST or COO? Cooper Companies received 354 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.42% of users gave Cooper Companies an outperform vote while only 56.11% of users gave West Pharmaceutical Services an outperform vote. CompanyUnderperformOutperformWest Pharmaceutical ServicesOutperform Votes27156.11% Underperform Votes21243.89% Cooper CompaniesOutperform Votes62566.42% Underperform Votes31633.58% Do analysts recommend WST or COO? West Pharmaceutical Services presently has a consensus target price of $332.50, indicating a potential upside of 54.29%. Cooper Companies has a consensus target price of $110.25, indicating a potential upside of 35.28%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, research analysts clearly believe West Pharmaceutical Services is more favorable than Cooper Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score West Pharmaceutical Services 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Cooper Companies 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70 Which has stronger valuation & earnings, WST or COO? West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWest Pharmaceutical Services$2.90B5.35$492.70M$6.3733.83Cooper Companies$3.93B4.15$392.30M$2.0639.56 Is WST or COO more profitable? West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.Company Net Margins Return on Equity Return on Assets West Pharmaceutical Services17.03% 18.60% 13.80% Cooper Companies 10.07%9.38%6.09% SummaryWest Pharmaceutical Services beats Cooper Companies on 12 of the 19 factors compared between the two stocks. Get Cooper Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COO vs. The Competition Export to ExcelMetricCooper CompaniesOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.30B$10.77B$5.42B$8.48BDividend YieldN/A0.96%5.22%4.11%P/E Ratio41.8034.5926.8020.05Price / Sales4.153.17393.93116.47Price / Cash15.8714.5338.2534.62Price / Book2.012.646.864.61Net Income$392.30M$224.27M$3.22B$248.19M7 Day Performance1.28%6.52%6.81%2.97%1 Month Performance3.56%23.58%13.72%16.58%1 Year Performance-15.77%-16.70%18.24%8.16% Cooper Companies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COOCooper Companies3.1925 of 5 stars$81.50-0.5%$110.25+35.3%-16.2%$16.30B$3.93B41.8014,000Positive NewsWSTWest Pharmaceutical Services4.6099 of 5 stars$219.20+2.9%$332.50+51.7%-37.1%$15.75B$2.90B32.7710,700Trending NewsAnalyst RevisionALGNAlign Technology4.8102 of 5 stars$189.00+3.9%$241.25+27.6%-31.7%$13.84B$3.98B33.6923,200Positive NewsMMSIMerit Medical Systems3.6648 of 5 stars$98.73+3.0%$107.78+9.2%+19.0%$5.83B$1.39B48.406,850Trending NewsInsider TradeAnalyst RevisionICUIICU Medical4.7793 of 5 stars$144.34+4.4%$192.67+33.5%+30.7%$3.55B$2.38B-31.5814,500Analyst UpgradeInsider TradeGap UpHAEHaemonetics4.1956 of 5 stars$70.23+3.0%$97.89+39.4%-27.7%$3.53B$1.36B27.652,820Analyst ForecastGap UpXRAYDENTSPLY SIRONA4.8421 of 5 stars$16.75+5.9%$20.36+21.6%-40.6%$3.34B$3.72B-8.0915,000Gap UpQDELQuidelOrtho4.5574 of 5 stars$37.42+3.0%$44.33+18.5%-23.6%$2.52B$2.78B-1.247,000Positive NewsGap UpNEOGNeogen3.4425 of 5 stars$6.50+8.9%$9.00+38.5%-54.6%$1.41B$906.00M-2.972,110High Trading VolumeSTAASTAAR Surgical4.1449 of 5 stars$20.27+4.4%$24.63+21.5%-55.0%$1.00B$279.13M-49.44960Positive NewsBuyback AnnouncementCERSCerus2.943 of 5 stars$1.35+4.7%$3.50+159.3%-31.3%$258.07M$185.14M-12.27290 Related Companies and Tools Related Companies West Pharmaceutical Services Competitors Align Technology Competitors Merit Medical Systems Competitors ICU Medical Competitors Haemonetics Competitors DENTSPLY SIRONA Competitors QuidelOrtho Competitors Neogen Competitors STAAR Surgical Competitors Cerus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Cooper Companies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cooper Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.